OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Chemokines and receptors in the development and progression of malignant tumors
Hanqing Zhao, Jun Jiang
Cytokine (2023) Vol. 170, pp. 156335-156335
Closed Access | Times Cited: 7
Hanqing Zhao, Jun Jiang
Cytokine (2023) Vol. 170, pp. 156335-156335
Closed Access | Times Cited: 7
Showing 7 citing articles:
Insights into the Tumor Microenvironment—Components, Functions and Therapeutics
Kornélia Baghy, Andrea Ladányi, Andrea Reszegi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17536-17536
Open Access | Times Cited: 28
Kornélia Baghy, Andrea Ladányi, Andrea Reszegi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17536-17536
Open Access | Times Cited: 28
Pluronic-Based Nanoparticles for Delivery of Doxorubicin to the Tumor Microenvironment by Binding to Macrophages
Chengrui Hu, Jun Wang, Xinxing Gao, et al.
ACS Nano (2024) Vol. 18, Iss. 22, pp. 14441-14456
Closed Access | Times Cited: 6
Chengrui Hu, Jun Wang, Xinxing Gao, et al.
ACS Nano (2024) Vol. 18, Iss. 22, pp. 14441-14456
Closed Access | Times Cited: 6
Targeted protein degradation with small molecules for cancer immunotherapy
Zichao Yang, Jianwei Xu, Xixiang Yang, et al.
Asian Journal of Pharmaceutical Sciences (2025), pp. 101058-101058
Open Access
Zichao Yang, Jianwei Xu, Xixiang Yang, et al.
Asian Journal of Pharmaceutical Sciences (2025), pp. 101058-101058
Open Access
Circulating interleukin-8 and osteopontin are promising biomarkers of clinical outcomes in advanced melanoma patients treated with targeted therapy
Lauretta Levati, Claudio Tabolacci, Antonio Facchiano, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 3
Lauretta Levati, Claudio Tabolacci, Antonio Facchiano, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 3
Unraveling the role of Major Vault Protein as a novel immune-related biomarker that promotes the proliferation and migration in pancreatic adenocarcinoma
Xinyi Wu, Leiyu Hao, Jianghua Lin, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Xinyi Wu, Leiyu Hao, Jianghua Lin, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Progression of radio-labeled molecular imaging probes targeting chemokine receptors
Heqing Yi, Lilin Qin, Xuemei Ye, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 195, pp. 104266-104266
Closed Access
Heqing Yi, Lilin Qin, Xuemei Ye, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 195, pp. 104266-104266
Closed Access
Chemokine‑ and chemokine receptor-based subtypes predict prognosis, immunotherapy and chemotherapy response in colorectal cancer patients
Wenjie Zhu, Shimin Zhao, Xiufeng Cheng, et al.
International Immunopharmacology (2024) Vol. 134, pp. 112172-112172
Closed Access
Wenjie Zhu, Shimin Zhao, Xiufeng Cheng, et al.
International Immunopharmacology (2024) Vol. 134, pp. 112172-112172
Closed Access
